MY160435A - A novel antiviral peptide against avian influenza virus h9n2 - Google Patents

A novel antiviral peptide against avian influenza virus h9n2

Info

Publication number
MY160435A
MY160435A MYPI20082061A MYPI20082061A MY160435A MY 160435 A MY160435 A MY 160435A MY PI20082061 A MYPI20082061 A MY PI20082061A MY PI20082061 A MYPI20082061 A MY PI20082061A MY 160435 A MY160435 A MY 160435A
Authority
MY
Malaysia
Prior art keywords
influenza virus
avian influenza
phages
aiv
peptides
Prior art date
Application number
MYPI20082061A
Other languages
English (en)
Inventor
Datin Paduka Dr Khatijah Mohd Yusof Prof
Prof Dr Abdul Rahman Omar Assoc
Aini Ideris Zprof
Rajik Mohamed
Original Assignee
Univ Putra Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Putra Malaysia filed Critical Univ Putra Malaysia
Priority to MYPI20082061A priority Critical patent/MY160435A/en
Priority to EP09762696.4A priority patent/EP2300492B1/en
Priority to PCT/MY2009/000071 priority patent/WO2009151313A1/en
Priority to JP2011513436A priority patent/JP5647111B2/ja
Priority to DK09762696.4T priority patent/DK2300492T3/da
Priority to US12/995,889 priority patent/US8883480B2/en
Publication of MY160435A publication Critical patent/MY160435A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/108—Orthomyxoviridae (F), e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MYPI20082061A 2008-06-12 2008-06-12 A novel antiviral peptide against avian influenza virus h9n2 MY160435A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
MYPI20082061A MY160435A (en) 2008-06-12 2008-06-12 A novel antiviral peptide against avian influenza virus h9n2
EP09762696.4A EP2300492B1 (en) 2008-06-12 2009-06-10 A novel antiviral peptide against avian influenza virus h9n2
PCT/MY2009/000071 WO2009151313A1 (en) 2008-06-12 2009-06-10 A novel antiviral peptide against avian influenza virus h9n2
JP2011513436A JP5647111B2 (ja) 2008-06-12 2009-06-10 トリインフルエンザウイルスｈ９ｎ２に対する新規な抗ウイルスペプチド
DK09762696.4T DK2300492T3 (da) 2008-06-12 2009-06-10 Hidtil ukendt antiviralt peptid mod aviær influenza h9n2
US12/995,889 US8883480B2 (en) 2008-06-12 2009-06-10 Antiviral peptide against avian influenza virus H9N2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20082061A MY160435A (en) 2008-06-12 2008-06-12 A novel antiviral peptide against avian influenza virus h9n2

Publications (1)

Publication Number Publication Date
MY160435A true MY160435A (en) 2017-03-15

Family

ID=41416902

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20082061A MY160435A (en) 2008-06-12 2008-06-12 A novel antiviral peptide against avian influenza virus h9n2

Country Status (6)

Country Link
US (1) US8883480B2 (https=)
EP (1) EP2300492B1 (https=)
JP (1) JP5647111B2 (https=)
DK (1) DK2300492T3 (https=)
MY (1) MY160435A (https=)
WO (1) WO2009151313A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12013500204A1 (en) * 2010-08-03 2013-04-01 Univ Washington Through Its Center For Commercialization Polypeptides for treating and/or limiting influenza infection
CN102830225B (zh) * 2012-09-24 2014-06-04 中国动物疫病预防控制中心 一种源于禽流感病毒自然弱毒株的血凝素和免疫抗原
MY184269A (en) * 2015-11-27 2021-03-30 Viramatix Sdn Bhd Broad-spectrum anti-influenza virus therapeutic peptides
US11376306B2 (en) 2017-05-26 2022-07-05 Viramatix Sdn Bhd Peptides and uses therefor as antiviral agents
US12421626B2 (en) 2018-06-29 2025-09-23 Fred Hutchinson Cancer Center Cell-stored barcoded deep mutational scanning libraries and uses of the same
CN109628641B (zh) * 2019-01-07 2022-03-01 广西壮族自治区兽医研究所 用于检测h7以及5个na亚型aiv的引物组合及其应用
CN109487011B (zh) * 2019-01-07 2022-03-01 广西壮族自治区兽医研究所 用于检测h5、h7和h9以及9个na亚型aiv的引物组合及其应用
CN109487012B (zh) * 2019-01-07 2020-09-22 广西壮族自治区兽医研究所 用于检测9个na亚型aiv的引物组合及其应用
US11821111B2 (en) 2019-11-15 2023-11-21 Fred Hutchinson Cancer Center Barcoded influenza viruses and deep mutational scanning libraries including the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
CA2323064C (en) * 1998-03-17 2011-05-31 Gendaq Limited Nucleic acid binding proteins
EP1167382A1 (en) * 1999-03-31 2002-01-02 Otsuka Pharmaceutical Co., Ltd. Influenza virus hemagglutinin-binding peptides
EP1441750A4 (en) * 2001-07-11 2006-10-18 Palatin Technologies Inc LINEAR AND CYCLIC PEPTIDES SPECIFIC TO THE MELANOCORTIN RECEPTOR
US7888121B2 (en) * 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
AU2006279323B2 (en) * 2005-08-16 2013-08-01 Merck Sharp & Dohme Corp. Influenza recombinant subunit vaccine
EP2003198A2 (en) * 2006-03-13 2008-12-17 Keio University Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza
US8685687B2 (en) * 2006-07-05 2014-04-01 The Scripps Research Institute Chimeric zinc finger recombinases optimized for catalysis by directed evolution
US8778847B2 (en) * 2007-06-13 2014-07-15 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Immunogenic peptides of influenza virus
WO2008154813A1 (fr) * 2007-06-15 2008-12-24 Xiamen University Anticorps monoclonaux se liant à l'hémagglutinine du virus de la grippe aviaire du sous type h5 et ses utilisations

Also Published As

Publication number Publication date
EP2300492B1 (en) 2014-06-04
WO2009151313A1 (en) 2009-12-17
EP2300492A1 (en) 2011-03-30
DK2300492T3 (da) 2014-09-01
US20110135676A1 (en) 2011-06-09
JP2011522561A (ja) 2011-08-04
JP5647111B2 (ja) 2014-12-24
US8883480B2 (en) 2014-11-11
EP2300492A4 (en) 2012-03-14

Similar Documents

Publication Publication Date Title
MY160435A (en) A novel antiviral peptide against avian influenza virus h9n2
Waldmann et al. A nanomolar multivalent ligand as entry inhibitor of the hemagglutinin of avian influenza
BR112014006390A2 (pt) anticorpos, domínios variáveis e cadeias feitos especialmente para uso humano
WO2007089753A3 (en) Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
EA200970255A1 (ru) Связывающие молекулы человека, способные нейтрализовать вирус гриппа h5n1, и их применение
NZ596032A (en) Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
EA201491051A1 (ru) Вакцины против вируса гриппа и их применения
MX2020004578A (es) Composiciones de casz y metodos de uso.
MX2013015323A (es) Polipeptidos de fusion de serpina y metodos de uso de los mismos.
MX360741B (es) Constructos de polipéptidos y sus usos.
NZ597692A (en) Anti-IGF antibodies
WO2010010467A3 (en) Neutralizing anti-influenza a virus antibodies and uses thereof
CL2007001488A1 (es) Anticuerpo humano o humanizado anti-integrina alfa5beta1; acido nucleico que lo codifica; vector y celula huesped que lo comprenden; procedimiento de produccion; composicion farmaceutica que lo comprende; y su uso para prevenir o tratar trastornos asociados con la integrina.
EA201590545A1 (ru) Полипептиды, содержащие fc с измененным гликозилированием и сниженной эффекторной функцией
MX2013007716A (es) Sistemas de expresion.
EA201791086A1 (ru) Человеческие антитела против гемагглютинина вируса гриппа
PE20120532A1 (es) ANTICUERPOS ANTI-ActRIIB
ATE552846T1 (de) Verbesserter grippeimpfstoff
EA201890315A1 (ru) Молекулы антител, связывающие cd22
CU20120095A7 (es) Antagonistas de pcsk9
CO6440535A2 (es) Antagonistas especificos del receptor fgf-r4
BR112014019901A8 (pt) Proteínas de fator viii recombinante
MX371202B (es) Receptores de células t humanas con alta afinidad modificados por medio de manipulación genética.
WO2010036970A3 (en) Influenza vaccines, antigens, compositions, and methods
BR112014028130A2 (pt) Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos